Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Botaneco Corp ADVVF

GREY:ADVVF - Post Discussion

Botaneco Corp > News out
View:
Post by mhillman on Feb 16, 2012 9:39am

News out

Great news, more sales coming.....

 

Botaneco to sell Dermylex in Canadian chain stores

Botaneco Corp (C:BOT)
Shares Issued 73,499,573
Last Close 2/10/2012
.09
Thursday February 16 2012 - News Release

Mr. Murray Bruce reports

MALIDERMA AND BOTANECO ANNOUNCE NATIONWIDE LAUNCH OF DERMYLEX; SEVERAL NATIONAL RETAIL CHAINS TO CARRY PRODUCT

Botaneco Corp., and its distributor, Maliderma Inc., have successfully launched Dermylex, a natural treatment for psoriasis, in a number of national Canadian retail chains. The product is commercialized under the Maliderma Dermylex trademark and can be found in Zellers nationally excluding Quebec, Loblaw's Pharmacy select stores, Real Canadian Superstore, Atlantic Superstore and Fortinos.

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities